WallStreetZenWallStreetZen

NASDAQ: DAWN
Day One Biopharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Day One Biopharmaceuticals earnings were -$84.3M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest DAWN earnings report on Sep 30, 2024 announced Q3 2024 earnings of $37.0M, down 940.4% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, DAWN reported annual earnings of -$188.9M, with 32.9% growth.

DAWN earnings history

Current Revenue
$102.0M
Current Earnings
-$84.3M
Current Profit Margin
-82.7%

DAWN Return on Equity

Current Company
-22.4%
Current Industry
19.9%
Current Market
35%
DAWN's Return on Equity (-22.4%)... subscribe to Premium to read more.
High Return on Equity Performance

DAWN Return on Assets

Current Company
-19.8%
Current Industry
1.3%
DAWN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when DAWN announces earnings.

DAWN Return on Capital Employed

Current Company
-14.9%
Current Industry
14.3%
DAWN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DAWN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
DAWN-$82.25M-$84.29MN/A-$1.03
ARVN-$299.40M-$308.60MN/A-$4.79
SPRY-$49.04M-$49.10MN/A-$0.51
MRVI$646.81M-$224.66MN/A-$1.64
INVA$137.16M$64.59M-22.91%$1.01
View Top Biotech Stocks

Day One Biopharmaceuticals Earnings Reports & History FAQ

What were Day One Biopharmaceuticals's earnings last quarter?

Day One Biopharmaceuticals (NASDAQ: DAWN) reported Q3 2024 earnings per share (EPS) of $0.38, up 170.37% year over year. Total DAWN earnings for the quarter were $37.04 million. In the same quarter last year, Day One Biopharmaceuticals's earnings per share (EPS) was -$0.54.

If you're new to stock investing, here's how to buy Day One Biopharmaceuticals stock.

Is Day One Biopharmaceuticals profitable or losing money?

As of the last Day One Biopharmaceuticals earnings report, Day One Biopharmaceuticals is currently losing money. Day One Biopharmaceuticals's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$84.29 million, a 51.7% decrease year over year.

What was DAWN's earnings growth in the past year?

As of Day One Biopharmaceuticals's earnings date in Q1 2025, Day One Biopharmaceuticals's earnings has grown year over year. DAWN earnings in the past year totalled -$84.29 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.